Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene.

Pascual A, Madamet M, Bertaux L, Amalvict R, Benoit N, Travers D, Cren J, Taudon N, Rogier C, Parzy D, Pradines B; French National Reference Centre for Imported Malaria Study Group.

Malar J. 2013 Nov 25;12:431. doi: 10.1186/1475-2875-12-431.

2.

Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum.

Durand R, Jafari S, Vauzelle J, Delabre JF, Jesic Z, Le Bras J.

Mol Biochem Parasitol. 2001 Apr 25;114(1):95-102.

PMID:
11356518
3.

In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.

Hao M, Jia D, Li Q, He Y, Yuan L, Xu S, Chen K, Wu J, Shen L, Sun L, Zhao H, Yang Z, Cui L.

Antimicrob Agents Chemother. 2013 Apr;57(4):1723-9. doi: 10.1128/AAC.02306-12. Epub 2013 Jan 28.

4.

Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt.

Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, Volkman SK, Wirth DF, Legrand E, Fidock DA, Neafsey DE, Musset L.

Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11672-7. doi: 10.1073/pnas.1507142112. Epub 2015 Aug 10.

5.

Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.

Mekonnen SK, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, Medhin G, Velavan TP.

Malar J. 2014 Jun 25;13:244. doi: 10.1186/1475-2875-13-244.

6.

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine.

Madamet M, Briolant S, Amalvict R, Benoit N, Bouchiba H, Cren J, Pradines B; French National Centre for Imported Malaria Study Group.

Parasit Vectors. 2016 Feb 9;9:77. doi: 10.1186/s13071-016-1358-z.

7.

Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.

Aguiar AC, Pereira DB, Amaral NS, De Marco L, Krettli AU.

Malar J. 2014 Feb 28;13:73. doi: 10.1186/1475-2875-13-73.

8.

Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.

Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-ngam P, Kuntawunginn W, Arsanok M, Buathong N, Chaorattanakawee S, Gosi P, Ta-aksorn W, Chanarat N, Sundrakes S, Kong N, Heng TK, Nou S, Teja-isavadharm P, Pichyangkul S, Phann ST, Balasubramanian S, Juliano JJ, Meshnick SR, Chour CM, Prom S, Lanteri CA, Lon C, Saunders DL.

Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.

PMID:
25877962
9.

Reduced heterozygosity at intragenic and flanking microsatellites of pfcrt gene establishes natural selection based molecular evolution of chloroquine-resistant Plasmodium falciparum in India.

Mallick PK, Singh R, Singh OP, Singh AK, Bhasin VK, Valecha N.

Infect Genet Evol. 2013 Dec;20:407-12. doi: 10.1016/j.meegid.2013.10.001. Epub 2013 Oct 12.

PMID:
24126360
10.

[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French.

12.

In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa.

Sisowath C, Petersen I, Veiga MI, Mårtensson A, Premji Z, Björkman A, Fidock DA, Gil JP.

J Infect Dis. 2009 Mar 1;199(5):750-7. doi: 10.1086/596738.

13.

Absence of association between piperaquine in vitro responses and polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe genes in Plasmodium falciparum.

Briolant S, Henry M, Oeuvray C, Amalvict R, Baret E, Didillon E, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2010 Sep;54(9):3537-44. doi: 10.1128/AAC.00183-10. Epub 2010 Jun 14.

14.

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso.

Sondo P, Derra K, Tarnagda Z, Nakanabo SD, Zampa O, Kazienga A, Valea I, Sorgho H, Ouedraogo JB, Guiguemde TR, Tinto H.

Pan Afr Med J. 2015 Jun 9;21:101. doi: 10.11604/pamj.2015.21.101.6437. eCollection 2015.

15.

High prevalence of PfCRT K76T mutation in Plasmodium falciparum isolates in Ghana.

Afoakwah R, Boampong JN, Egyir-Yawson A, Nwaefuna EK, Verner ON, Asare KK.

Acta Trop. 2014 Aug;136:32-6. doi: 10.1016/j.actatropica.2014.03.030. Epub 2014 Apr 12.

PMID:
24727053
16.

[Plasmodium falciparum: point mutations of pcfrt and chloroquine susceptibility].

Durand R, Le Bras J.

Ann Pharm Fr. 2001 Sep;59(5):312-8. French.

PMID:
11787424
17.

A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.

Edaye S, Reiling SJ, Leimanis ML, Wunderlich J, Rohrbach P, Georges E.

Mol Biochem Parasitol. 2014 Jun;195(1):34-42. doi: 10.1016/j.molbiopara.2014.05.006. Epub 2014 Jun 8.

PMID:
24914817
19.

The detection of pfcrt and pfmdr1 point mutations as molecular markers of chloroquine drug resistance, Pahang, Malaysia.

Atroosh WM, Al-Mekhlafi HM, Mahdy MA, Surin J.

Malar J. 2012 Aug 1;11:251. doi: 10.1186/1475-2875-11-251.

20.

Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea.

Mita T, Kaneko A, Hombhanje F, Hwaihwanje I, Takahashi N, Osawa H, Tsukahara T, Masta A, Lum JK, Kobayakawa T, Ishizaki T, Björkman A.

Acta Trop. 2006 May;98(2):137-44. Epub 2006 Apr 18.

PMID:
16620743

Supplemental Content

Support Center